“SGLT2 Inhibitors: Cardiorenal Mechanisms How a glucose-lowering drug became a foundational heart and kidney therapy” (2026) Diabzen, 4(14), pp. 28–29. Available at: https://thediabzen.com/index.php/d/article/view/54 (Accessed: 28 July 2026).